EUVIMED · CrossrefZeitschrift
Recent Patents on Cardiovascular Drug Discovery
ISSN 1574-8901 · Bentham Science Publishers Ltd.
Neueste Artikel
Steerable Sheath Technology in the Ablation of Atrial Fibrillation
The Role of Omega-3 Polyunsaturated Fatty Acids Supplementation in Childhood: A Review
Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension
A Review of Sirt1 and Sirt1 Modulators in Cardiovascular and Metabolic Diseases
Targets for the Treatment of Erectile Dysfunction: Is NO/cGMP Still the Answer?
Bioabsorbable Coronary Stents - Are These the Next Big Thing in Coronary Angioplasty?
Old Versus New Anticoagulants: Focus on Pharmacology
MicroRNA-21 as Therapeutic Target in Cancer and Cardiovascular Disease
Patent Selections
Edaravone (3-Methyl-1-Phenyl-2-Pyrazolin-5-one), A Novel Free Radical Scavenger, for Treatment of Cardiovascular Diseases
New Approaches to Atherosclerotic Cardiovascular Disease. The Potentialities of Torcetrapib
Combination of a Sterol Absorption Inhibitor and Cardiovascular Agents for the Treatment of Dyslipidemia
Soluble Epoxide Hydrolase: A Novel Target for the Treatment of Hypertension
Methods for Identifying Cardiovascular Agents: A Review
Non-Steroidal LXR Agonists; An Emerging Therapeutic Strategy for the Treatment of Atherosclerosis
Patent Annotations
The Vascular Endothelin System in Hypertension - Recent Patents and Discoveries
Recently Patented Applications of Homologous Cellular and Extracellular Agents as Therapeutics or Targets for the Prevention of Restenosis Post- Angioplasty
Telmisartan, its Potential Therapeutic Implications in Cardiometabolic Disorders
Novel Molecular Targets in the Treatment of Cardiac Hypertrophy
Role of PPAR in Cardiovascular Diseases
Oxidative Stress in Cardiovascular Disease: A New Avenue Toward Future Therapeutic Approaches
Patent Selections
Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs
Levosimendan: A Novel Agent in Heart Failure
99mTc-N-DBODC5: A Novel Myocardial Perfusion Imaging Agent for Diagnosis of Coronary Artery Disease, a Review
Patent Annotations
Vasopressin Receptor Antagonists in Heart Failure
Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase
Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
EUVIMED